ABC | Volume 114, Nº5, Maio 2020

Posicionamento Posicionamento da Sociedade Brasileira de Cardiologia para Gravidez e Planejamento Familiar na Mulher Portadora de Cardiopatia – 2020 Arq Bras Cardiol. 2020; 114(5):849-942 9. Lumbers ER, Pringle KG. Roles of the circulating renin- angiotensin aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol. 2014;306(2):R91-101. 10. Ouzoounian JG,ElkayamU.Physiologicchangesduringnormalpregnancy and delivery. Cardiol Clin 2012; 30(3): 317-29 11. Langesæter E, Dyer RA. Maternal haemodynamic changes during spinal anaesthesia for cesarean section. Curr Opin Anaesthesiol. 2011;24(3):242-8. 12. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153-68. 13. Cui C, Yang S, Zhang J, Wang G, Huang S, Li A, et al. Trimester-specific coagulation and anticoagulation reference intervals for healthy pregnancy. Thromb Res. 2017 Aug;156:82-6. 14. Puranik BM, Kaore SB, KurhadeGA, Agrawal SD, Patwardhan SA, Kher JR. A longitudinal study of pulmonary function tests during pregnancy. Indian J Physiol Pharmacol. 1994;38(2):129-32. 15. Dzieciolowska-Baran E, Teul-Swiniarska I, Gawlikowska-Sroka A, Poziomkowska-Gesicka I, Zietek Z. Rhinitis as cause of respiratory disorders during pregnancy. Adv Exp Med Biol. 2013 Jun;755:213-20. 16. Hegewald MJ. Respiratory physiology in pregnancy. Clin Chest Med. 2011;32(1):1-13. 17. Manalo-Estrella, Barker AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol. 1967;83(4):336-41 18. Andrade J, Ávila WS. Doença cardiovascular, gravidez e planejamento familiar. Capitulo 2: Modificaçoes hemodinâmicas da Gravidez. Editora Atheneu. São Paulo, SP. 2003: p.11- 20. 19. Davies GA, HerbertWN. Assessment andmanagement of cardiac disease in pregnancy. J Obstet Gynaecol Can. 2007;29(4):331-6. 20. Mishra M, Chambers JB, Jakson G. Murmurs in pregnancy: na audit of echocardiography. BMJ. 1992;304(6839):1413-4. 21. Bacha CA, Rezende CAL, Cury GC. Avaliação dos fatores de risco para o desenvolvimento de complicações clínicas secundárias à cardiopatia na gestante. J Bras Gynec. 1997;107(9):315-22 22. Vause S, Clarke B, Tower C, Hay C, Knight M. Mechanical prosthetic heart valves (MPHV) in pregnancy are associated with a high risk of maternal and fetal morbidity and mortality. Heart. 2017;103(19):1557. 23. Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, et al. Vitamin K antagonists and pregnancy outcome. Amulti-center prospective study. Thromb Haemost. 2006;95(6): 949-57. 24. Manning FA. Fetal biophysical profile. Obstet Gynecol Clin North Am. 1999;26(4):557-77. 25. Force US, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(22):2308-14. 26. Morton A, Teasdale S. Review article: Investigations and the pregnant woman in the emergency department - part 2: Point-of-care ultrasound, electrocardiography, respiratory function tests and radiology. Emerg Med Australas. 2018;30(6):749-53. 27. Tanindi A, Akgun N, Pabuccu EG, Gursoy AY, Yüce E, Tore HF, et al. Electrocardiographic P-Wave duration, QT interval, T peak to end interval and Tp-eQT Ratio in pregnancy with respect to trimesters. Ann Noninvasive Electrocardiol. 2016;21(2):169-74. 28. BarbosaMM, Nunes MC, Campos FilhoO, Camarozano A, Rabischoffsky A, Maciel BC, et al. Sociedade Brasileira de Cardiologia. Diretrizes das Indicações da Ecocardiografia. Arq Bras Cardiol. 2009;93(6 Suppl 3):e265-302. 29. Ain DL, Narula J, Sengupta PP. Cardiovascular imaging and diagnostic procedures in pregnancy. Cardiol Clin. 2012;30(3):331-41. 30. Ge S, Maulik D. Introduction: From fetal echocardiography to fetal cardiology: A journey of over half a century. Echocardiography. 2017;34(12):1757-9. 31. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183-242. Erratum in: Circulation. 2014;129(21):e512. 32. Feldman DM. Blood pressure monitoring during pregnancy. Blood Press Monit. 2001;6(1):1-7. 33. Nobre F, Mion Jr D, Gomes MA, Barbosa EC, Rodrigues CI, Neves MF, et al. 6ª Diretrizes de Monitorização Ambulatorial da Pressão Arterial e 4ª Diretrizes de Monitorização Residencial da Pressão Arterial. Arq Bras Cardiol. 2018;110(5 Suppl 1):1-29. 34. Lorga Filho A, Cintra FD, Lorga A, Grupi CJ, Pinho C, Moreira DA, et al. Recommendations of the Brazilian Society of Cardiac Arrhythmias for holter monitoring services. Arq Bras Cardiol. 2013;101(2):101-5. 35. Lui GK, Silversides CK, Khairy P, Fernandes SM, Valente AM, Nickolaus MJ, et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation. 2011;123(3):242-8 36. Picano E, Vano E. The radiation issue in cardiology: the time for action is now. Cardiovasc Ultrasound. 2011 Nov ;9:35 37. Bedetti G, Botto N, Andreassi MG , Traino C, Vano E, Picano E. Cumulative patiente effective dose in cardiology. Br J Radiol. 2008;81(969):699-705. 38. D'IppolitoI G, Medeiros RB. Exames radiológicos na gestação. Radiol Bras. 2005;38(6):447-50. 39. HamadaN,FujimichiY.Classificationofradiationeffects fordose limitation purposes: history, current situation and future prospects. J Radiat Res. 2014;55(4):629-40. 40. Wang PI, Chong ST, Kielar AZ, Kelly AM, Knoepp UD, Mazza MB, et al. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations . AJR Am J Roentgenol. 2012;198(4):778-84. 41. Brent RL. The effect of embrionic and fetal exposure to x-ray, microwaves, and ultrasond: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989;16(5):347-68. 42. Tirada N, Dreizin D, Khati NJ, Akin EA, Zeman RK. Imaging pregnant and lactating patients Radiographics. 2015;35(6):1751-65. 43. Plaut S. Radiation protection in the X-ray department. London : Butterworth &Heinemann; 1993. p.157. 44. Johnson PT, Deshmukh S, Mahesh M, Grant KL, Fishman EK. CT dose radiation applications: available tools on the latest generation of CT scanners. J Am Coll Radiol. 2013;10(1):37-41. 45. CollettiPM.PET-CT inthepregnantpatient. ImageWisely.[Internet]. [Cited in 2014 Jan 14]. Available from: https://www.imagewisely.org/~/media/ ImageWisely-Files/NuclMed/PETCT-inthe_Pregnant-Patient.pdf 46. Wang PI, Chong ST, Kielar AZ, Kelly AM, Knoepp UD, Mazza MB, et al. Imaging of pregnant and lactating patients II Evidence-based review and recommendations. AJR Am J Roentgenol. 2012;198(4):785-92. 47. Ray JG, Vermeulen MJ, Bharatha A, MontaneraWJ, Park AL. Associations between MRI exposure during pregnancy and fetal and chidhood outcomes. JAMA. 2016;316(9):952-61. 48. PieperPG.UsedeMedicationforcardiovasculardiseaseduringpregnancy. Nat Rev Cardiol. 2015;12(12):718-29. 49. Ruys TP, Maggioni A, Johnson MR, Sliwa K, Tavazzi L, Schwerzmann M, et al. Cardiac medication during pregnancy, data from the ROPAC. Int J Cardiol. 2014;177(1):124-8. 50. Haas DM, Marsh DJ, Dang DT, Parker CB, Wing DA, Simhan HN, et al. Prescription and Other Medication Use in Pregnancy. Obstet Gynecol. 2018;131(5):789-98. 931